Rhiannon David

Rhiannon David

Company: AstraZeneca

Job title: Director - Microphysiological Systems


Panel Discussion: The Influence of Physicochemical & ADME Properties on Delivering Oral PROTACs 1:45 pm

How useful are ADME properties for design and optimisation of oral PROTACs? Opportunities of different analytical and in silico tools to advance drug design Challenges faced in synthesis and purification of PROTACsRead more

day: Day 2 Track B PM

Improving Pre-Clinical Safety Assessment with Microphysiological Systems 12:15 pm

Outline the context of use of microphysiological systems (MPS) to generate safety and efficacy data for drug development with improved clinical relevance over more traditional 2D cell culture and animal models Highlight examples of data generated from these systems that demonstrate the utility of MPS for safety assessment Current challenges to the adoption and/or development…Read more

day: Day 2 Track B AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.